Our findings of increased ESRD risk in variant SOD2 Val/Val carriers is aligned with several studies concluding that this polymorphism increases the risk of diabetic nephropathy in both T1DM and T2DM patients [9,10,15]. The gene discussed is SOD2; the disease is type 2 diabetes mellitus.